However, we note that only one of the five epitope-mapped autoantibodies, anti-TPO IgG, have been previously reported in proteome-scale autoantibody studies of COVID-19, with a reported prevalence ranging from 012,16,27,43,54 to 2%15. This evidence concerns the gene TPO and COVID-19.